## Facts

- Vincent J. Bifolck sued Philip Morris, Inc. under the Connecticut Product Liability Act (CPLA) after his wife, Jeanette D. Bifolck, died of lung cancer at age 42.
- Jeanette Bifolck began smoking Marlboro and Marlboro Lights cigarettes in adolescence and continued for many years.
- The complaint alleged the cigarettes were defectively designed and that the design made them unnecessarily addictive and carcinogenic.
- The allegations included that the manufacturer added ingredients (including carcinogenic ingredients) and used processes that affected the composition and delivery of tobacco and nicotine in smoke.
- The plaintiff sought compensatory damages and statutory punitive damages under the CPLA.
- While the case was pending in federal district court, that court certified questions to the Connecticut Supreme Court concerning the design-defect standard under the CPLA and the measure of punitive damages under Conn. Gen. Stat. § 52-240b.

## Issues

1. What standard governs CPLA design-defect claims, including the role of Restatement (Second) of Torts § 402A and comment i, and whether Connecticut should adopt the Restatement (Third) design-defect approach.
2. Whether statutory punitive damages under Conn. Gen. Stat. § 52-240b are limited by the common-law rule capping punitive damages at litigation expenses (minus taxable costs).

## Decision

- The court declined to adopt the Restatement (Third) of Torts design-defect framework as the governing standard for CPLA design-defect claims.
- For strict-liability design-defect claims under the CPLA, the court held the modified consumer expectation test is the primary test and the only test applicable to the certified case.
- The court clarified that “unreasonably dangerous” is not rigidly controlled by Restatement (Second) comment i in negligence-based design claims under the CPLA.
- The court reaffirmed that comment i’s reference to “good tobacco” does not categorically bar design-defect claims against cigarette manufacturers where the claim is that the product was engineered to increase addictiveness and carcinogenicity.
- The court held the common-law litigation-expense cap does not apply to punitive damages awarded under Conn. Gen. Stat. § 52-240b; the statute creates an independent punitive-damages measure capped at no more than two times the compensatory damages awarded.

## Legal Principles

- Connecticut strict-liability design-defect claims under the CPLA are governed primarily by the modified consumer expectation test, especially for complex products.
- Connecticut does not require, as an exclusive element of a design-defect claim, the Restatement (Third)’s reasonable alternative design formulation.
- Strict liability and negligence are distinct theories under the CPLA: strict liability centers on the product’s condition, while negligence centers on the manufacturer’s conduct; the meaning of “unreasonably dangerous” is informed by this distinction.
- Restatement (Second) § 402A comment i does not immunize cigarette manufacturers from design-defect claims when the allegations involve purposeful design choices increasing addictiveness and toxicity.
- CPLA punitive damages under Conn. Gen. Stat. § 52-240b are statutory and are not confined to common-law punitive damages measured by litigation expenses; they are capped by a statutory multiple of compensatory damages.

## Conclusion

The Connecticut Supreme Court answered certified questions by confirming that CPLA strict-liability design-defect claims—particularly for complex products—are governed by the modified consumer expectation test rather than the Restatement (Third) approach, and by holding that CPLA punitive damages under § 52-240b are not limited to common-law litigation-cost measures but are capped at up to twice compensatory damages.


Bifolck v. Philip Morris, Inc., 324 Conn. 402, 152 A.3d 1183 (Conn. 2016)